607 Results

People

  1. Shukla
    Shukla
  2. Steinherz
    Steinherz
  3. Trippett
    Trippett
  4. Kentsis
    Kentsis
  5. Forlenza
    Forlenza
  6. Ladanyi
    Ladanyi
  7. Sulis
    Sulis
  8. O'Reilly
    O'Reilly
  9. Cifani
    Cifani
  10. Kernan
    Kernan

Groups

  1. Hematologic Malignancies Service (607)
  2. Pediatrics, Department of (607)
  3. Center for Hematologic Malignancies (554)
  4. Pediatric Leukemia (455)
  5. GSK Faculty (220)
  6. Tow Center for Developmental Oncology (TCDO) (206)
  7. Sloan Kettering Institute Faculty (148)
  8. Department of Medicine (147)
  9. Hematologic Malignancies Research (114)
  10. Molecular Pharmacology and Chemistry Program Faculty (114)
  1. "Hematologic Malignancies Service"
Formats
  1. Journal Article (349)
  2. Meeting Abstract (232)
  3. Review (11)
  4. Research Letter (5)
  5. Editorial (4)
  6. Book Section (2)
  7. Conference Paper (2)
  8. Correspondence (1)
  9. Guidelines (1)
Groups
  1. Hematologic Malignancies Service (607)
  2. Pediatrics, Department of (607)
  3. Center for Hematologic Malignancies (554)
  4. Pediatric Leukemia (455)
  5. GSK Faculty (220)
  6. Tow Center for Developmental Oncology (TCDO) (206)

More Groups

People
  1. Peter Steinherz (221)
  2. Neerav Shukla (159)
  3. Tanya Trippett (126)
  4. Alex Kentsis (103)
  5. Christopher Forlenza (49)
  6. Marc Ladanyi (44)

More People

Years
  1. 2025 (11)
  2. 2024 (27)
  3. 2023 (37)
  4. 2022 (34)
  5. 2021 (29)
  6. 2020 (29)

More Years

Publications
  1. Blood (125)
  2. Journal of Clinical Oncology (61)
  3. Pediatric Blood and Cancer (57)
  4. Cancer Research (22)
  5. Cancer (18)
  6. Journal of Pediatric Hematology/Oncology (16)

More Publications

Publishers
  1. American Society of Hematology (134)
  2. American Society of Clinical Oncology (69)
  3. Wiley Periodicals, Inc (57)
  4. American Association for Cancer Research (56)
  5. Nature Publishing Group (39)
  6. Elsevier Inc. (33)

More Publishers

Results (607)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Frequency and prognostic significance of recurrent gene mutations in pediatric B-ALL: Report from the DFCI ALL Consortium
    Meeting Abstract

    Gotti, G.; Puligandla, M.; Stevenson, K. E.; Mar, B. G.; Asselin, B. L.; Athale, U.; Clavell, L. A.; Cole, P. D.; Gennarini, L. M.; Kahn, J. M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Brentuximab vedotin plus bendamustine for pediatric patients with relapsed/refractory Hodgkin lymphoma: A multi-institution retrospective analysis
    Meeting Abstract

    Forlenza, C. J.; Gulati, N.; Mauguen, A.; Absalon, M. J.; Castellino, S. M.; Franklin, A.; Keller, F. G.; Shukla, N.
    Blood (2020)

    Fulltext@MSK | Save
  • Safety, pharmacokinetics and preliminary activity of cobimetinib in paediatric and young adult patients With refractory/relapsed solid tumours: iMATRIX-cobi, a phase I/II study
    Meeting Abstract

    Geoerger, B.; Verschuur, A.; Toledano, H.; Campbell-Hewson, Q.; Langevin, A. M.; Patel, D.; Pereira, L.; Cheeti, S.; Hutchinson, K. E.; Devlin, C.; more...
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Phase 1 study of tazemetostat, an enhancer of zeste homolog-2 (EZH2) inhibitor, in pediatric patients with relapsed/refractory integrase interactor 1 (INI1)-negative tumors
    Meeting Abstract

    Chi, S.; Bourdeaut, F.; Laetsch, T.; Fouladi, M.; Macy, M.; Makin, G.; Shukla, N.; Wetmore, C.; Margol, A.; Casanova, M.; more...
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Larotrectinib demonstrates durable efficacy and safety in an expanded dataset of pediatric patients with TRK fusion cancer
    Meeting Abstract

    Mascarenhas, L.; Albert, C.; Pappo, A.; Geoerger, B.; Doz, F.; Federman, N.; Nagasubramanian, R.; Bielack, S.; Dubois, S.; Morgenstern, D.; more...
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Covalent inhibition of NSD1 histone methyltransferase
    Journal Article

    Huang, H.; Howard, C. A.; Zari, S.; Cho, H. J.; Shukla, S.; Li, H.; Ndoj, J.; González-Alonso, P.; Nikolaidis, C.; Abbott, J.; more...
    Nature Chemical Biology (2020)

    Fulltext@MSK | Save
  • Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia
    Journal Article

    Oshima, K.; Zhao, J.; Pérez-Durán, P.; Brown, J. A.; Patiño-Galindo, J. A.; Chu, T.; Quinn, A.; Gunning, T.; Belver, L.; Ambesi-Impiombato, A.; more...
    Nature Cancer (2020)

    Fulltext@MSK | Save
  • Aggressive hematopoietic malignancy characterized by biallelic loss of SMARCB1
    Journal Article

    Kinnaman, M. D.; Hamill, D.; Yabe, M.; Powell, J.; Benhamida, J.; Hasselblatt, M.; Neumann, M.; Vokuhl, C.; Koelsche, C.; von Deimling, A.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • The first report of pediatric patients with solid tumors treated with venetoclax
    Meeting Abstract

    Goldsmith, K. C.; Verschuur, A.; Morgenstern, D. A.; van Eijkelenburg, N.; Federico, S. M.; Fraser, C.; Forlenza, C. J.; Ziegler, D. S.; Gerber, N. U.; Khaw, S. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Prospective agnostic germline testing in pediatric cancer patients
    Meeting Abstract

    Fiala, E.; Kennedy, J.; Kemel, Y.; Mauguen, A.; Mandelker, D.; Zehir, A.; Birsoy, O.; Bouvier, N.; Maio, A.; Latham, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save